Evidence map›Paper›PMID 35959367›Full record

ArticleFrontiers in cellular and infection microbiology2022

A poly(dimethylsiloxane)-based solid-phase microchip platform for dual detection of Pseudorabies virus gD and gE antibodies.

Jiaojiao Pan, Yufang Li, Tongyan Wang, Jingfeng Chang, Liying Hao, Junjie Chen, Wuping Peng, Junhua Deng, Baicheng Huang, Kegong Tian

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Jiaojiao PanLuoyang Putai Biotech Co., Ltd., Luoyang, China.
Yufang LiLuoyang Zhongke Biochip Technology Co., Ltd., Luoyang, China.
Tongyan WangNational Research Center for Veterinary Medicine, Luoyang, China.
Jingfeng ChangLuoyang Putai Biotech Co., Ltd., Luoyang, China.
Liying HaoLuoyang Putai Biotech Co., Ltd., Luoyang, China.
Junjie ChenDepartment of Statistical Science, University College London, London, United Kingdom.
Wuping PengLuoyang Putai Biotech Co., Ltd., Luoyang, China.
Junhua DengLuoyang Putai Biotech Co., Ltd., Luoyang, China.
Baicheng HuangNational Research Center for Veterinary Medicine, Luoyang, China.
Kegong TianNational Research Center for Veterinary Medicine, Luoyang, China.
Luoyang Institute of Science and Technology · CNUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudorabies caused by pseudorabies virus (PRV) infection is still a major disease affecting the pig industry; its eradication depends on effective vaccination and antibody (Ab) detection. For a more rapid and accurate PRV detection method that is suitable for clinical application, here, we established a poly(dimethylsiloxane)-based (efficient removal of non-specific binding) solid-phase protein chip platform (blocking ELISA) for dual detection of PRV gD and gE Abs. The purified gD and gE proteins expressed in baculovirus were coated into the highly hydrophobic nanomembrane by an automatic spotter, and the gray values measured by a scanner were used for the S/N (sample/negative) value calculation (gD and gE Abs standard, positive: S/N value ≤0.6; negative: S/N value >0.7; suspicious: 0.6 < S/N ≤ 0.7). The method showed an equal sensitivity in the gD Ab test of immunized pig serum samples compared to the neutralization test and higher sensitivity in the gE Ab test compared to the commercial gE Ab detection kit. In the clinical evaluation, we found an agreement of 100% (122/122) in the gD Ab detection compared to the neutralization test and an agreement of 97.5% (119/122) in the gE Ab detection compared to the commercial PRV gE Ab detection kit. In summary, the protein chip platform for dual detection of PRV gD and gE Abs showed high sensitivity and specificity, which is suitable for PRV immune efficacy evaluation and epidemic monitoring.

Indexed as

Herpesvirus 1, SuidPseudorabiesSwine DiseasesAnimalsAntibodies, ViralDimethylpolysiloxanesSwineViral Envelope ProteinsAntibodies, ViralbaysilonDimethylpolysiloxanesViral Envelope Proteinsclinical evaluationdual detectionpoly(dimethylsiloxane)protein chipPseudorabies virus

Identifiers

PMID35959367
PMCPMC9360482
OpenAlexW4287877375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.